Shares of Express Scripts Holding Co. (NASDAQ:ESRX) have earned an average rating of “Hold” from the twenty-three ratings firms that are covering the company. Three equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and nine have assigned a buy rating to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $82.12.

ESRX has been the topic of several research reports. Credit Suisse Group AG reissued an “outperform” rating and issued a $85.00 target price on shares of Express Scripts Holding in a report on Monday, October 3rd. Jefferies Group reaffirmed a “buy” rating and set a $88.00 price objective on shares of Express Scripts Holding in a research note on Monday, August 29th. Sanford C. Bernstein reaffirmed an “underperform” rating and set a $68.00 price objective on shares of Express Scripts Holding in a research note on Tuesday, September 6th. Zacks Investment Research raised Express Scripts Holding from a “hold” rating to a “buy” rating and set a $78.00 price objective on the stock in a research note on Wednesday, October 5th. Finally, Cowen and Company reaffirmed a “positive” rating and set a $83.00 price objective on shares of Express Scripts Holding in a research note on Wednesday, June 15th.

Shares of Express Scripts Holding (NASDAQ:ESRX) traded down 1.311% during mid-day trading on Tuesday, hitting $69.645. The company had a trading volume of 938,330 shares. The firm has a 50-day moving average of $71.59 and a 200-day moving average of $73.82. Express Scripts Holding has a 12 month low of $65.55 and a 12 month high of $89.20. The company has a market cap of $43.89 billion, a PE ratio of 17.209 and a beta of 1.16.

Express Scripts Holding (NASDAQ:ESRX) last posted its earnings results on Monday, July 25th. The company reported $1.57 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $1.57. The company had revenue of $25.20 billion for the quarter, compared to analyst estimates of $25.42 billion. Express Scripts Holding had a return on equity of 23.98% and a net margin of 2.64%. Express Scripts Holding’s revenue was down .9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.44 earnings per share. On average, analysts expect that Express Scripts Holding will post $6.36 EPS for the current year.

In other news, VP Christopher A. Mcginnis sold 1,785 shares of the business’s stock in a transaction on Monday, September 12th. The stock was sold at an average price of $70.77, for a total value of $126,324.45. Following the sale, the vice president now owns 4,955 shares of the company’s stock, valued at approximately $350,665.35. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Woodrow A. Myers, Jr. sold 12,036 shares of the business’s stock in a transaction on Wednesday, September 14th. The stock was sold at an average price of $70.40, for a total value of $847,334.40. Following the completion of the sale, the director now directly owns 14,918 shares in the company, valued at approximately $1,050,227.20. The disclosure for this sale can be found here. Company insiders own 0.54% of the company’s stock.

Several hedge funds have recently bought and sold shares of ESRX. Barrow Hanley Mewhinney & Strauss LLC boosted its stake in Express Scripts Holding by 49.9% in the second quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 14,646,371 shares of the company’s stock worth $1,110,195,000 after buying an additional 4,874,043 shares during the last quarter. BlackRock Fund Advisors boosted its stake in Express Scripts Holding by 1.3% in the first quarter. BlackRock Fund Advisors now owns 9,508,996 shares of the company’s stock worth $653,173,000 after buying an additional 121,543 shares during the last quarter. Massachusetts Financial Services Co. MA boosted its stake in Express Scripts Holding by 7.6% in the second quarter. Massachusetts Financial Services Co. MA now owns 7,768,039 shares of the company’s stock worth $588,818,000 after buying an additional 547,365 shares during the last quarter. Boston Partners boosted its stake in Express Scripts Holding by 16.5% in the second quarter. Boston Partners now owns 7,063,742 shares of the company’s stock worth $535,432,000 after buying an additional 998,544 shares during the last quarter. Finally, Ameriprise Financial Inc. boosted its stake in Express Scripts Holding by 19.5% in the second quarter. Ameriprise Financial Inc. now owns 6,278,887 shares of the company’s stock worth $475,934,000 after buying an additional 1,025,739 shares during the last quarter. 88.52% of the stock is currently owned by institutional investors.

About Express Scripts Holding

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

5 Day Chart for NASDAQ:ESRX

Receive News & Stock Ratings for Express Scripts Holding Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Co. and related stocks with our FREE daily email newsletter.